Skip to main content
Equibles

Christine A. Poon

Board Member

Regeneron Pharmaceuticals, Inc. (REGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get REGN alerts

About Christine A. Poon

Christine A. Poon is recorded as Board Member at Regeneron Pharmaceuticals, Inc. (REGN) since June 12, 2020. Regeneron Pharmaceuticals, Inc. reported in an 8-K filed April 17, 2023 that Christine A. Poon was appointed Lead Independent Director of the Board. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.

“Effective upon the expiration of Dr. Vagelos’s term, the Board plans to elect Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of the Company, and George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of the Company, as Co-Chairs of the Board (in addition to Dr. Schleifer’s and Dr. Yancopoulos’s continued roles as President and Chief Executive Officer and President and Chief Scientific Officer, respectively) and to designate Christine A. Poon as the Lead Independent Director of the Board.”
Regeneron Pharmaceuticals, Inc. Form 8-K, filed April 17, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Regeneron Pharmaceuticals, Inc.

Recent activity